title: Carbamazepine-induced systemic lupus erythematosus.
abstract: A 21-year-old woman suffering from bipolar affective disorder developed systemic lupus erythematosus (SLE) with characteristic laboratory findings, 18 months after starting carbamazepine maintenance treatment. SLE receded after withdrawal of carbamazepine and treatment with anti-inflammatory drugs. Although both the spontaneous occurrence of SLE and the psychosis as a sign of CNS involvement of SLE cannot be excluded, SLE could be considered as an adverse effect of carbamazepine.
authors.affiliation: Psychiatrische Klinik, University of Munich, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Schmidt
authors.forename: M
authors.initials: M
authors.lastname: Welcker
authors.forename: W
authors.initials: W
authors.lastname: Greil
authors.forename: M
authors.initials: M
authors.lastname: Schattenkirchner
mesh_terms: D000328:Adult; D000974:Antibodies, Antinuclear / Q000032:analysis; D001714:Bipolar Disorder / Q000188:drug therapy*; D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D000974:Antibodies, Antinuclear; D002220:Carbamazepine